Using genetic and molecular technologies to better understand follicular lymphoma
Dr Karthik Nath, The Mater Research Institute (Brisbane)
Funding period: 2019-2022
This PhD is kindly supported by the Bill Long Charitable Trust, managed by Equity Trustees.
This research undertaken by Dr Nath aims to develop a deeper understanding of the biology of Follicular Lymphoma (the second most common Non-Hodgkins Lymphoma) by employing evolving genetic and molecular laboratory technologies in prognostic paradigms.
Dr Nath and team hopes to incorporate these elements into upfront prognostication in Follicular Lymphoma that would represent a practical means of improving diagnostic techniques and treatment approaches with real-world applicability.
The second part of this research aims to help engender precision medicine in the treatment of patients with Follicular Lymphoma. By applying patient-specific immunological, molecular and genetic markers in prognostication, the research team is confident they will improve patient outcomes through individualised treatment approaches.
Utilising these highly specific markers may also help the greater research community understand disease processes and be incrementally beneficial to public health medicine. The team is hopeful individualising treatment will empower patients and reinforce the importance of psychosocial aspects involved in cancer care.
PhD scholarships are co-funded by the Leukaemia Foundation and the Haematology Society of Australia and New Zealand (HSANZ).